ECO Animal Health receives new USA and Canada label claim for Aivlosin®

ECO Animal Health
[shareaholic app="share_buttons" id_name="post_below_content"]

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has received a new US and Canadian label claim indication for Aivlosin® Water Soluble Granules in pigs.

Following years of research into the sow reproductive safety of Aivlosin® WSG, a new ‘sow safety’ indication has been approved by the US Food & Drug Administration (FDA). Prior to this approval, the label indication restricted WSG to be used only in the drinking water of swine intended for slaughter and not for use in lactating or pregnant females, or males and females intended for breeding.

The new label indication will be ‘For use only in the drinking water of swine intended for slaughter and female swine intended for breeding. Not for use in male swine intended for breeding’.

Meanwhile, the Veterinary Drugs Directorate in Canada has also approved the removal of label statements regarding ‘not for use in lactating or pregnant females and females intended for breeding’.

David Halls, ECO Animal Health CEO, commented: “We are pleased to have received this new label claim approved by the FDA which gives permission for ECO to sell into an additional market segment. This is testament to the continued market development of our products and these new claims and labels further enhance the safety message already used for Aivlosin in pigs.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
ECO Animal Health Group plc has announced the disposal of ECOmectin® Horsepaste to ACME Drugs S.r.l in Italy, focusing on core species of pigs and poultry.
ECO Animal Health Group plc (LON:EAH) updates on trading and business progress, with strong revenue driven by Aivlosin® and R&D investments for future growth.
ECO Animal Health Group plc has appointed Dr. Joachim Hasenmaier as a Non-Executive Director. With extensive experience in the animal health industry, Dr. Hasenmaier's appointment is expected to drive growth and capitalize on future opportunities.
ECO Animal Health Group plc has announced that its trademark, ECOVAXXIN®, has been approved by the European Union, providing extensive protection in key markets for animal health products. This trademark will brand a family of vaccine products, supporting the company's strategy of growth through R&D.

Search

Search